Unknown

Dataset Information

Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control study.


ABSTRACT:

SUBMITTER: Bellofiore C 

PROVIDER: S-EPMC11931317 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature